Cargando…

Prolactinomas: evolution after menopause

OBJETIVE: The aim was to assess the evolution of tumor size and prolactin (PRL) levels in patients with micro and macroprolactinomas diagnosed and treated with dopamine agonists during fertile age, and the effects of suspension of drugs after menopause. Retrospective study, 29 patients with prolacti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mallea-Gil, Maria Susana, Manavela, Marcos, Alfieri, Analia, Ballarino, Maria Carolina, Chervin, Alberto, Danilowicz, Karina, Diez, Sabrina, Day, Patricia Fainstein, García-Basavilbaso, Natalia, Glerean, Mariela, Guitelman, Mirtha, Katz, Débora, Loto, Monica Graciela, Martinez, Marcela, Miragaya, Karina, Moncet, Daniel, Rogozinski, Amelia Susana, Servidio, Marisa, Stalldecker, Graciela, Vitale, Marcelo, Boero, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Endocrinologia e Metabologia 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118912/ https://www.ncbi.nlm.nih.gov/pubmed/26909481 http://dx.doi.org/10.1590/2359-3997000000138

Ejemplares similares

MON-432 Symptomatic Pituitary Metastases: A Report of 16 Cases
por: Loto, Monica, et al.
Publicado: (2019)

Pegvisomant in acromegaly: a multicenter real-life study in Argentina
por: Basavilbaso, Natalia Ximena Garcia, et al.
Publicado: (2019)

SAT-451 Acromegaly and Thyroid Cancer
por: Danilowicz, Karina, et al.
Publicado: (2019)

SUN-448 Giant Prolactinomas: A Follow-Up of 25 Years with Dopamine Agonists
por: Mallea Gil, Susana, et al.
Publicado: (2019)

Acromegaly and thyroid cancer: analysis of evolution in a series of patients
por: Danilowicz, Karina, et al.
Publicado: (2020)

SAT-455 Analysis of a Group of Prolactinomas Resistant to Treatment with Dopamine Agonists at a University Hospital in Buenos Aires, Argentina
por: Gonzalez Pernas, Mariana, et al.
Publicado: (2019)

Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina
por: Day, Patricia Fainstein, et al.
Publicado: (2016)

Germinoma with Involvement of Midline and Off-Midline Intracranial Structures
por: Loto, Monica Graciela, et al.
Publicado: (2014)

Long-term outcome after bilateral adrenalectomy in Cushing’s disease with focus on Nelson’s syndrome
por: Cohen, Ana C., et al.
Publicado: (2019)

Implementing a screening program for acromegaly in Latin America: necessity versus feasibility
por: Danilowicz, Karina, et al.
Publicado: (2016)

Histologically confirmed isolated IgG4-related hypophysitis: two case reports in young women
por: Sosa, Gabriela Alejandra, et al.
Publicado: (2014)

Temozolomide Therapy for Aggressive Pituitary Tumors: Results in a Small Series of Patients from Argentina
por: Bruno, Oscar D., et al.
Publicado: (2015)

MON-326 Non Functioning Pituitary Adenomas (NFPA): Sex Related Differences in Presentation, Clinical Features and Outcomes
por: Rosmino, Josefina, et al.
Publicado: (2020)

Production, Preservation, and Transfer of South American Camelid Embryos
por: Trasorras, Virginia L., et al.
Publicado: (2017)

PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes
por: Cristina, Carolina, et al.
Publicado: (2007)

Pegvisomant-Induced Cholestatic Hepatitis in an Acromegalic Patient with UGT1A1 (⁎) 28 Mutation
por: Mallea-Gil, Maria Susana, et al.
Publicado: (2016)

Treatment of Prolactinoma
por: Inder, Warrick J., et al.
Publicado: (2022)

Approach to the Patient With Prolactinoma
por: Auriemma, Renata S, et al.
Publicado: (2023)

Patient-focussed outcomes in acromegaly
por: Guitelman, Mirtha, et al.
Publicado: (2013)

New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A
por: Fuertes, Mariana, et al.
Publicado: (2018)

Resistant prolactinoma: Is it monoclonal or polyclonal?
por: Kumar, K. V. S. Hari, et al.
Publicado: (2013)

Managing Prolactinomas during Pregnancy
por: Almalki, Mussa Hussain, et al.
Publicado: (2015)

Serum Survivin Increases in Prolactinoma
por: Dellal, Fatma Dilek, et al.
Publicado: (2015)

Simultaneous Convexity Meningioma and Prolactinoma
por: Figueroa-Angel, Vladimir, et al.
Publicado: (2017)

Current Challenges in the Management of Prolactinomas
por: Maiter, Dominique
Publicado: (2015)

An interesting case of cystic prolactinomas
por: Gopal, Raju A., et al.
Publicado: (2020)

Italian Guidelines for the Management of Prolactinomas
por: Cozzi, Renato, et al.
Publicado: (2023)

Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?
por: De Sousa, Sunita M C
Publicado: (2022)

SUN-494 A Case of Hyperthyroidism with Multiple Recurrences of Neutropenia After Stopping Methimazole
por: Gil, Susana Mallea, et al.
Publicado: (2020)

Non-functioning pituitary adenomas and pregnancy: one-center experience and review of the literature
por: Rosmino, Josefina, et al.
Publicado: (2020)

Cabergoline Treatment in Invasive Giant Prolactinoma
por: Alsubaie, Sadeem, et al.
Publicado: (2014)

Treatment of Prolactinomas in Low-Income Countries
por: Kruljac, Ivan, et al.
Publicado: (2015)

DICER1 mutation and pituitary prolactinoma
por: Cotton, Ellena, et al.
Publicado: (2018)

AIP variant causing familial prolactinoma
por: Carty, David M., et al.
Publicado: (2020)

Giant Prolactinoma Causing Proptosis and Stroke
por: Wortham, Joy, et al.
Publicado: (2021)

Update in Pathogenesis, Diagnosis, and Therapy of Prolactinoma
por: Fukuhara, Noriaki, et al.
Publicado: (2022)

The Effect of Prolactinoma on Tear Film Function
por: Doğan, Cezmi, et al.
Publicado: (2022)

Experience with Dopamine Agonists in the Treatment of Prolactinomas
por: Barabash, Nadiya Ye., et al.
Publicado: (2022)

Prolactinoma: Clinical Characteristics, Management and Outcome
por: Irfan, Hira, et al.
Publicado: (2022)

The Role of Aromatase Inhibitors in Male Prolactinoma
por: Akirov, Amit, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tcbhtt105sluufjj5iqf1gs5tk